Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Total Liabilities (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Total Liabilities for 17 consecutive years, with $71.5 billion as the latest value for Q4 2025.

  • Quarterly Total Liabilities fell 6.14% to $71.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $71.5 billion through Dec 2025, down 6.14% year-over-year, with the annual reading at $71.5 billion for FY2025, 6.14% down from the prior year.
  • Total Liabilities for Q4 2025 was $71.5 billion at Bristol Myers Squibb, down from $78.3 billion in the prior quarter.
  • The five-year high for Total Liabilities was $82.5 billion in Q1 2024, with the low at $61.5 billion in Q2 2023.
  • Average Total Liabilities over 5 years is $71.6 billion, with a median of $73.5 billion recorded in 2021.
  • The sharpest move saw Total Liabilities decreased 12.6% in 2023, then skyrocketed 32.19% in 2024.
  • Over 5 years, Total Liabilities stood at $73.3 billion in 2021, then fell by 10.38% to $65.7 billion in 2022, then fell by 0.04% to $65.7 billion in 2023, then increased by 16.05% to $76.2 billion in 2024, then decreased by 6.14% to $71.5 billion in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $71.5 billion, $78.3 billion, and $77.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.